Organigram Global (OGI) Tax Provisions (2018 - 2025)
Organigram Global (OGI) posted quarterly Tax Provisions of -$73873.1 for Q1 2025, up 99.53% quarter-over-quarter from -$15.6 million in Q3 2020.
Organigram Global (OGI) Tax Provisions (2018 - 2025) Analysis & Trends
Organigram Global (OGI) has reported Tax Provisions for 4 consecutive years, with -$73873.1 the latest figure, recorded in Q1 2025.
- In Q1 2025, Tax Provisions changed N/A year-over-year to -$73873.1; the TTM figure through Mar 2025 stood at -$23.5 million (changed N/A YoY), while the FY2025 annual figure was -$9.9 million, changed N/A from the prior year.
- Tax Provisions improved to -$73873.1 in Q1 2025 per OGI's latest filing, from -$15.6 million in the prior quarter.
- Across five years, Tax Provisions topped out at -$73873.1 in Q1 2025 and bottomed at -$73873.1 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Organigram Global | 158.95 Mn | 158.83 Mn | 28.97 Mn | -49.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -73,873.15 |
| Aug 31, 2020 | -15.58 Mn |
| May 31, 2020 | -7.13 Mn |
| Feb 29, 2020 | -698,000.00 |
| Aug 31, 2019 | -4.76 Mn |
| May 31, 2019 | -1.68 Mn |
| Feb 28, 2019 | -620,000.00 |
| Nov 30, 2018 | 12.79 Mn |